Emsita-M SR100/1000 Tablet contains Sitagliptin and Metformin, a combination medication designed to help control blood glucose levels. Sitagliptin enhances the activity of incretin hormones that help regulate insulin release and reduce glucose production after meals. Metformin works by decreasing glucose production in the liver and improving the body’s response to insulin. The sustained release formulation allows the medicine to release gradually, helping maintain stable blood sugar levels for a longer duration. Proper glycemic control is essential for preventing complications related to diabetes and maintaining overall metabolic balance. The medicine is usually taken according to the dosage prescribed by a healthcare professional. Healthy lifestyle measures such as balanced diet, physical activity, and weight management may further support treatment effectiveness. When used as directed, Emsita-M SR100/1000 Tablet helps support effective blood glucose management and improved metabolic health.